- Home
- CWT vs IBRX Comparison
CWT vs IBRX Comparison
Compare CWT & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWT
- IBRX
- Stock Information
- Founded
- CWT 1926
- IBRX 2014
- Country
- CWT United States
- IBRX United States
- Employees
- CWT N/A
- IBRX N/A
- Industry
- CWT Water Supply
- IBRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CWT Utilities
- IBRX Health Care
- Exchange
- CWT Nasdaq
- IBRX Nasdaq
- Market Cap
- CWT 2.8B
- IBRX 2.3B
- IPO Year
- CWT N/A
- IBRX N/A
- Fundamental
- Price
- CWT $46.12
- IBRX $2.53
- Analyst Decision
- CWT Strong Buy
- IBRX Strong Buy
- Analyst Count
- CWT 2
- IBRX 6
- Target Price
- CWT $54.50
- IBRX $9.83
- AVG Volume (30 Days)
- CWT 346.6K
- IBRX 10.3M
- Earning Date
- CWT 10-30-2025
- IBRX 11-11-2025
- Dividend Yield
- CWT 2.59%
- IBRX N/A
- EPS Growth
- CWT N/A
- IBRX N/A
- EPS
- CWT 2.28
- IBRX N/A
- Revenue
- CWT $990,685,000.00
- IBRX $56,600,000.00
- Revenue This Year
- CWT N/A
- IBRX $629.94
- Revenue Next Year
- CWT $6.23
- IBRX $109.91
- P/E Ratio
- CWT $20.29
- IBRX N/A
- Revenue Growth
- CWT 0.63
- IBRX 4227.22
- 52 Week Low
- CWT $41.64
- IBRX $1.83
- 52 Week High
- CWT $54.75
- IBRX $7.48
- Technical
- Relative Strength Index (RSI)
- CWT 53.39
- IBRX 47.77
- Support Level
- CWT $43.94
- IBRX $2.42
- Resistance Level
- CWT $45.70
- IBRX $2.75
- Average True Range (ATR)
- CWT 0.81
- IBRX 0.13
- MACD
- CWT 0.04
- IBRX -0.01
- Stochastic Oscillator
- CWT 92.05
- IBRX 22.88
About CWT California Water Service Group
California Water Service Group is a U.S. water and utilities holding company based in California. The company engages in the production, treatment, storage, distribution, and sale of water for various uses. The firm operates through its subsidiaries, which can be divided between regulated and unregulated businesses. The regulated public utilities subsidiaries operate in California, New Mexico, Washington, and Hawaii. The unregulated subsidiaries provide water utility services to private companies and municipalities. The company derives the majority of its revenue from its operations in California and, overall, from residential customers.
About IBRX ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.